 |
Top 10 Lung Cancer treatment startups in USA
Updated: May 01, 2024 |
1
Funding: $3B
At Moderna, we are pioneering the development of a new class of drugs made of messenger RNA (mRNA). This novel drug platform builds on the discovery that modified mRNA can direct the body’s cellular machinery to produce nearly any protein of interest, from native proteins to antibodies and other entirely novel protein constructs that can have therapeutic activity inside and outside of cells.
At Moderna, we are pioneering the development of a new class of drugs made of messenger RNA (mRNA). This novel drug platform builds on the discovery that modified mRNA can direct the body’s cellular machinery to produce nearly any protein of interest, from native proteins to antibodies and other entirely novel protein constructs that can have therapeutic activity inside and outside of cells.
2
Funding: $1.6B
IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL)
IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL)
3
Funding: $1.3B
Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
4
Funding: $749.5M
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
5
Funding: $733.3M
Auris Health is developer of robotic microsurgical devices designed for ophthalmic procedures that help diagnose cancer using controllers.
Auris Health is developer of robotic microsurgical devices designed for ophthalmic procedures that help diagnose cancer using controllers.
6
Funding: $313M
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
7
Funding: $219.5M
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
8
Funding: $165M
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
9
Funding: $106M
Totus Medicines is a provider of chemical biology technologies by creating life-changing covalent drugs.
Totus Medicines is a provider of chemical biology technologies by creating life-changing covalent drugs.
10
Funding: $95M
Lantern Pharma is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action.
Lantern Pharma is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action.
Ad
Advertise your startup
11
Funding: $82.9M
Genprex is a clinical stage gene therapy company developing molecular therapies to better target lung cancer cells. Their new approach to treating cancer is based upon our novel proprietary technology platform, including our initial product candidate, Oncoprex immunogene therapy, or Oncoprex.
Genprex is a clinical stage gene therapy company developing molecular therapies to better target lung cancer cells. Their new approach to treating cancer is based upon our novel proprietary technology platform, including our initial product candidate, Oncoprex immunogene therapy, or Oncoprex.
12
Funding: $82.4M
Rain Therapeutics is a biotech company laser focused on a subtype of non-small cell lung cancer
Rain Therapeutics is a biotech company laser focused on a subtype of non-small cell lung cancer
13
Funding: $75M
OncoMyx Therapeutics develops oncolytic immunotherapies to orchestrate an immune response and treat cancer.
OncoMyx Therapeutics develops oncolytic immunotherapies to orchestrate an immune response and treat cancer.
14
Funding: $73M
OncoCyte focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
OncoCyte focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
15
Funding: $65M
Actuate Therapeutics is a biopharmaceutical company focused on the development of compounds for use in the treatment of cancer, and inflammatory diseases leading to fibrosis and neurodegeneration. Our work has led to some fascinating results around anti-tumor activity in the brain, pancreas, lungs, and breasts.
Actuate Therapeutics is a biopharmaceutical company focused on the development of compounds for use in the treatment of cancer, and inflammatory diseases leading to fibrosis and neurodegeneration. Our work has led to some fascinating results around anti-tumor activity in the brain, pancreas, lungs, and breasts.
17
Funding: $14.4M
20/20 GeneSystems develops and commercializes innovative, proprietary diagnostics tests that aid in the fight against cancer.
20/20 GeneSystems develops and commercializes innovative, proprietary diagnostics tests that aid in the fight against cancer.
19
Funding: $1.8M
Deton is transforming the understanding and treatment of lung disease by providing complete and timely lung health information thru Aerosol Biopsy
Deton is transforming the understanding and treatment of lung disease by providing complete and timely lung health information thru Aerosol Biopsy
20
Funding: $1.2M
Peer Medical allows lung cancer patients to anonymously share treatments with each other
Peer Medical allows lung cancer patients to anonymously share treatments with each other
21
Funding: $100K
Astraeus Technologies is a startup that is creating a noninvasive Lung cancer screening test.
Astraeus Technologies is a startup that is creating a noninvasive Lung cancer screening test.
22
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.